Karim Bitar Sells 132,253 Shares of ConvaTec Group PLC (LON:CTEC) Stock

ConvaTec Group PLC (LON:CTEC) insider Karim Bitar sold 132,253 shares of ConvaTec Group stock in a transaction on Friday, March 14th. The stock was sold at an average price of GBX 256 ($3.33), for a total transaction of £338,567.68 ($439,755.40).

Karim Bitar also recently made the following trade(s):

• On Monday, March 17th, Karim Bitar sold 436,692 shares of ConvaTec Group stock. The shares were sold at an average price of GBX 256 ($3.33), for a total transaction of £1,117,931.52 ($1,452,047.69).

ConvaTec Group Stock Up 0.5 %

Shares of CTEC stock traded up GBX 1.40 ($0.02) on Tuesday, hitting GBX 259.40 ($3.37). The stock had a trading volume of 373,079,156 shares, compared to its average volume of 27,658,520. The company has a quick ratio of 0.96, a current ratio of 2.26 and a debt-to-equity ratio of 85.32. The business has a 50 day moving average price of GBX 245.67 and a 200 day moving average price of GBX 234.36. The company has a market cap of £6.60 billion, a PE ratio of 43.68, a P/E/G ratio of 0.93 and a beta of 0.64. ConvaTec Group PLC has a one year low of GBX 211.80 ($2.75) and a one year high of GBX 295.20 ($3.83).

ConvaTec Group Increases Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, April 17th will be issued a $0.05 dividend. This is an increase from ConvaTec Group’s previous dividend of $0.02. This represents a dividend yield of 1.36%. The ex-dividend date is Thursday, April 17th. ConvaTec Group’s payout ratio is presently 84.20%.

Analyst Upgrades and Downgrades

Separately, Berenberg Bank reissued a “buy” rating and set a GBX 310 ($4.03) target price on shares of ConvaTec Group in a research note on Wednesday, March 5th.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.